Rankings
▼
Calendar
FULC Q1 2022 Earnings — Fulcrum Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
FULC
Fulcrum Therapeutics, Inc.
$436M
Q1 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$3M
-45.9% YoY
Gross Profit
-$15M
-587.9% margin
Operating Income
-$26M
-1003.0% margin
Net Income
-$26M
-1000.3% margin
EPS (Diluted)
$-0.64
QoQ Revenue Growth
-48.8%
Cash Flow
Operating Cash Flow
-$22M
Free Cash Flow
-$22M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$220M
Total Liabilities
$31M
Stockholders' Equity
$189M
Cash & Equivalents
$33M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$3M
$5M
-45.9%
Gross Profit
-$15M
-$12M
-32.0%
Operating Income
-$26M
-$17M
-52.5%
Net Income
-$26M
-$17M
-52.5%
← FY 2022
All Quarters
Q2 2022 →